ClinicalTrials.gg
RecruitingNCT07632833Updated Oct 9, 2026

The Use of a Comfort Tote to Improve Recovery in Pediatric and Adolescent Patients After Surgery

An interventional study of The Therapeutic Comfort Tote and The Modified Comfort Tote in Adolescent Idiopathic Scoliosis, Postoperative Pain, Acute and Postoperative Nausea and Vomiting, sponsored by Columbia University. Recruiting at 1 site in United States. Open to participants aged 12 Years to 21 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Columbia University · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 9, 2026Now RecruitingFirst site in United States+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
12 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,181 studies in Pain, Postoperative with a site in United States — 204 open to participants now, 237 under way, 25 of them phase 3. Pain, Postoperative · United States.

Planned enrollment
728th of 1,099
50 · median 76
Started
2026
with 67 others
No phase
373 of 1,181
68 open now
Primary completion
2027-09
later than 163 of 236 live
Registered
1,152nd of 1,181
by date

Among the 1,181 studies in Pain, Postoperative with a site in United States, this one is the 728th largest by planned enrollment of the 1,099 interventional ones that give a count, is one of 68 that started in 2026, is one of 373 with no phase, reaches primary completion later than 163 of the 236 other live ones, and was the 1,152nd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

204 of the 1,181 studies in Pain, Postoperative with a site in United States are open now. Recruiting first, the newest first:

198 more — sign in →

All 204 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 12 Years to 21 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,181 studies in Pain, Postoperative with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if the use of Comfort Tote can treat pain and anxiety in adolescents with idiopathic scoliosis undergoing posterior spinal fusion. The study aims to answer two questions:

  1. To characterize the effectiveness and determine the impact of integrative therapy interventions of the Comfort Tote use in reducing self-reported pain, anxiety, and stress among pediatric patients with AIS undergoing PSF. By comparing self-reported pain, anxiety, and stress scores, as well as documented Morphine Milligram Equivalents (MMEs) and Numeric Rating Scale (NRS) pain scores, between patients using non-therapeutic and therapeutic Comfort Totes.
  2. To evaluate the impact of an educational video on the use of the Comfort Tote. This will assess whether the inclusion of instructional content enhances understanding and application of the Comfort Tote, thereby improving patient outcomes in pain management, anxiety reduction, and overall satisfaction with care. It is hypothesized that the therapeutic Comfort Tote intervention with the educational video will provide the highest patient satisfaction and greater tote usage, with decreased patient pain, stress, and anxiety levels. The findings from this pilot study will provide crucial insights into establishing a new standard of care for pediatric patients undergoing PSF and potentially provide baseline data for use in larger, multicenter randomized controlled trials.
Read the detailed description

The single-blind randomized controlled trial pilot study will include 50 adolescent participants aged 12 to 21, evenly distributed between the two study arms: a non-therapeutic modified Comfort Tote with written instructions and a therapeutic Comfort Tote with written instructions and an educational video. The RCT will be a single-blind study, with patients blinded to the intervention they receive. All totes will be available in English and Spanish, and patients will receive them during the pre-operative visit with the orthopedics team post-randomization. The non-therapeutic Comfort Tote will contain the following items: journal, coloring book, coloring pencils/markers, stuffed animal, non-scented hand lotion, earplugs, sleep eye mask, and fidget spinner/pop-it. This Tote will come with written instructions. The therapeutic Comfort Tote will contain the following items: aromatherapy kit including two essential oils: Balance and Clear, a firm and soft stress ball, five acupressure points including a plasticized map, Mindful Breathing, ImaginAction, EFT/Tapping, and a journal with prompts and coloring pencils included. The patients will also receive written instructions and watch a video outlining the contents of the tote and how to use each item.

Both prospective and retrospective methods will be used. A survey will be delivered at the final, postoperative in-hospital appointment between patients and their surgical team. The survey will evaluate their experience with the Comfort Tote. Primary outcomes include the impact of each Comfort Tote item on post-operative pain, stress, and anxiety scores. These will be assessed through a Qualtrics survey using a scale ranging from "did not help at all" to "helped a little" to "helped a lot". Every patient will be linked to a respective page to receive a Qualtrics survey, and this link will be texted/emailed to them. Caregivers will also receive a Qualtrics survey about their experiences with the Comfort Tote, sent via text or email. General patient pain scores will also be evaluated using measures in EPIC, including the Numeric Rating Scale (NRS).

Secondary outcomes include tote item usage, length of hospital stay (LOS), Intensive Care Unit (ICU) LOS, total direct costs (TDC), morphine milligram equivalents (MME) administered during the hospital stay, opioid prescriptions at discharge, surgical site infections, readmissions or unanticipated return to clinic, and mobility scores through the AM PAC mobility score determined by physical therapy. Tote usage indicates results from patients recording which tote components they used, collected through a post-operative Qualtrics survey. Secondary outcomes will also include whether or not patients took Gabapentin, and patients will receive a calendar with instructions upon discharge to document opioid use at home. Caregivers will also be surveyed at the final postoperative in-hospital appointment to understand their experiences with the Comfort Tote.

Aim 1: Evaluate whether the Comfort Tote intervention leads to greater reductions in self-reported pain, stress, and anxiety among patients diagnosed with adolescent idiopathic scoliosis (AIS) undergoing posterior spinal fusion (PSF).

Aim 2: Assess the effect of the therapeutic Comfort Tote on hospital resource utilization - specifically length of stay, ICU days, and direct costs - as well as opioid exposure, including in-hospital morphine milligram equivalents and opioid prescriptions at discharge. Additionally, this study will examine clinical outcomes, including surgical-site infections, unanticipated readmissions or clinic visits, and discharge mobility, using AM-PAC mobility scores.

Aim 3: Assess patient caregivers' experiences with and perceptions of the Comfort Tote's usefulness using data collected via a brief structured survey.

03

Conditions studied

  • Adolescent Idiopathic Scoliosis
  • Postoperative Pain, Acute
  • Postoperative Nausea and Vomiting
  • Anxiety

Keywords

  • Posterior spinal fusion
  • Integrative therapy
04

Who can participate

Ages eligible
12 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of all genders, racial, and ethnic groups aged between 10 and 21 that have had been diagnosed with AIS requiring surgical correction with PSF.
  • Patients must be scheduled to undergo PSF at Morgan Stanley Children's Hospital of NYP.
  • The patients and their parent(s)/legal guardian(s) must also provide , for those under 18 years old.
  • The patient population will include mental health conditions such as anxiety and/or depression and all surgery levels.

Exclusion criteria

Exclusion Criteria:

  • Patients who have had growing rods and revisions, those who have local or systemic infections, those with anemia, cardiovascular diseases, or osteoporosis, and patients with severe medical comorbidities such as neurological or developmental condition that precludes engagement with the Comfort Tote
  • Patients with two or more chronic conditions (excluding AIS)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Therapeutic Comfort Tote

    Participants will be randomly assigned to receive the Therapeutic Comfort Tote.

    Other: The Therapeutic Comfort Tote

  • Placebo comparator
    Modified Comfort Tote

    Participants will be randomly assigned to receive the Modified Comfort Tote.

    Other: The Modified Comfort Tote

Interventions

  • OtherThe Therapeutic Comfort Tote

    The therapeutic Comfort Tote will contain the following items: aromatherapy kit including two essential oils: Balance and Clear, a firm and soft stress ball, five acupressure points including a plasticized map, Mindful Breathing, ImaginAction, EFT/Tapping, and a journal with prompts and coloring pencils included. The patients will also receive written instructions and watch an educational video outlining the contents of the tote and how to use each item.

  • OtherThe Modified Comfort Tote

    The non-therapeutic Comfort Tote will contain the following items: journal, coloring book, coloring pencils/markers, stuffed animal, non-scented hand lotion, earplugs, sleep eye mask, and fidget spinner/pop-it. This Tote will come with written instructions.

06

What researchers measure

Primary outcomes

  1. Primary Outcome: Pain

    Impact of each item used in the Comfort Tote on post-operative pain. This will be assessed through a Qualtrics survey across a scale ranging from did not help at all, helped a little, or helped a lot. The number of participants who responded to each of the three options will be reported. Every patient will be linked to a respective page to receive a Qualtrics survey, and this link will be texted/emailed to them.

    Time frame: From surgery date up to four weeks after surgery

  2. Primary Outcome: Stress

    Impact of each item used in the Comfort Tote on post-operative stress. This will be assessed through a Qualtrics survey across a scale ranging from did not help at all, helped a little, or helped a lot. The number of participants who responded to each of the three options will be reported. Every patient will be linked to a respective page to receive a Qualtrics survey, and this link will be texted/emailed to them.

    Time frame: From surgery date up to four weeks after surgery

  3. Primary Outcome: Anxiety

    Impact of each item used in the Comfort Tote on post-operative anxiety. This will be assessed through a Qualtrics survey across a scale ranging from did not help at all, helped a little, or helped a lot. The number of participants who responded to each of three options will be reported. Every patient will be linked to a respective page to receive a Qualtrics survey, and this link will be texted/emailed to them.

    Time frame: From surgery date up to four weeks after surgery

  4. Primary Outcome: Patient Pain scores

    General patient pain scores will be evaluated through measures in EPIC, including Numeric Rating Scale (NRS) pain scores (0-10, 0 being no pain, and 10 being the most severe pain experienced).

    Time frame: From surgery date up to four weeks after surgery

  5. Primary Outcome: Caregiver's impression

    Caregivers will also receive a Qualtrics survey to understand their experiences with the Comfort Tote, which will be texted/emailed to them. The scale will include a range of responses from did not help, to help a little, to help a lot. The number of participants who responded to each of the three options will be reported.

    Time frame: From surgery date up to four weeks after surgery

Secondary outcomes

  1. Secondary Outcomes: Tote items usage

    Secondary outcomes include tote item usage. Tote usage indicates results from patients recording which tote components they used, collected through a post-operative Qualtrics survey. The patients will register if they used the item even once - yes, no, or not sure.

    Time frame: From surgery date up to four weeks after surgery

  2. Length of stay

    Secondary outcomes include length of hospital stay (LOS) in days.

    Time frame: From surgery date until discharge date, assessed up to four weeks after surgery

  3. ICU LOS

    Secondary outcomes include Intensive Care Unit (ICU) LOS in days.

    Time frame: From surgery date until discharge date, assessed up to four weeks after surgery

  4. Total direct cost

    Secondary outcomes include total direct costs (TDC) in dollars.

    Time frame: From surgery date until discharge date, assessed up to four weeks after surgery

  5. MME use during hospital admission

    Secondary outcomes include morphine milligram equivalents (MME) administered during the hospital stay from the EPIC-recorded pain team's notes.

    Time frame: From surgery date until discharge date, assessed up to four weeks after surgery

  6. Opioid prescriptions at discharge

    Secondary outcomes include opioid prescriptions at discharge in total milligrams and milligrams per dose.

    Time frame: From discharge from hospital until up to four weeks after surgery

  7. Surgical site infections

    Secondary outcomes include surgical site infections.

    Time frame: From surgery date until up to four weeks after surgery

  8. Readmissions

    Secondary outcomes include readmissions, defined as hospital admissions within 30 days of discharge.

    Time frame: Assessed up to 4 weeks after surgery

  9. Unanticipated return to clinic

    Secondary outcomes include unanticipated return to clinic.

    Time frame: Assessed up to 4 weeks after surgery

  10. Mobility Scores

    Secondary outcomes include mobility scores via AM PAC mobility scores assigned by physical therapy. Includes six possible scores: 1-Rolling over in bed 2- Sitting up from lying down 3- Sitting down and standing up from a chair 4- Moving from sitting to standing (transfers)5- Walking 6- Climbing stairs

    Time frame: Assessed up to 4 weeks after surgery

  11. Gabapentin use

    Secondary outcomes include whether or not patients took Gabapentin.

    Time frame: From surgery date until up to four weeks after surgery

  12. Postoperative opioid use at home

    Secondary outcomes include postoperative opioid use via a calendar with instructions upon discharge to document opioid use at home.

    Time frame: From discharge until up to four weeks after surgery

07

Study locations

1 of 1 sites recruiting
  • NewYork Presbyterian Hospital / Columbia University Irving Medical Center
    New York, New York 10018, United States
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Sep 2027, 9 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Oct 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2026
First posted
Jun 8, 2026
StartEst.
Dec 2026was Aug 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Jun 30, 2028
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 9, 2026
Sites
1 site added — first site in United States
Show site
  • NewYork Presbyterian Hospital / Columbia University Irving Medical Center · New York, United States
Oct 9, 2026
Start date
Aug 10, 2026→Dec 2026
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • NewYork Presbyterian Hospital / Columbia University Irving Medical Center · New York, United States
    Start date Aug 10, 2026→Dec 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07632833
Responsible party
Mirna Giordano (Associate Professor in Pediatrics, Columbia University) — Principal investigator
First posted
Jun 8, 2026
Start date
Dec 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Oct 9, 2026

Study contacts

Mirna Giordano
Contact
mg2267@cumc.columbia.edu
917664260
Mirna Giordano, MD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion